These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26341481)

  • 41. Cardioprotective effect of breviscapine: inhibition of apoptosis in H9c2 cardiomyocytes via the PI3K/Akt/eNOS pathway following simulated ischemia/reperfusion injury.
    Wang J; Ji SY; Liu SZ; Jing R; Lou WJ
    Pharmazie; 2015 Sep; 70(9):593-7. PubMed ID: 26492644
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adenosine-A1 receptors activation restores the suppressed cardioprotective effects of ischemic preconditioning in hyperhomocysteinemic rat hearts.
    Balakumar P; Singh H; Reddy K; Anand-Srivastava MB
    J Cardiovasc Pharmacol; 2009 Sep; 54(3):204-12. PubMed ID: 19568176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Rush to the fire: FGF21 extinguishes metabolic stress, metaflammation and tissue damage.
    Luo Y; Ye S; Chen X; Gong F; Lu W; Li X
    Cytokine Growth Factor Rev; 2017 Dec; 38():59-65. PubMed ID: 28887067
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of FGF21 in the pathogenesis of cardiovascular disease.
    Zhang Y; Liu D; Long XX; Fang QC; Jia WP; Li HT
    Chin Med J (Engl); 2021 Dec; 134(24):2931-2943. PubMed ID: 34939977
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Fibroblast growth factor 21 plays a protective role in cardiovascular diseases by inducing autophagy].
    Li YK; He SY; Wang C; Shi YC; Liu JH
    Sheng Li Xue Bao; 2022 Aug; 74(4):633-638. PubMed ID: 35993214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FGF21: a promising therapeutic agent for alcoholic cardiomyopathy?
    Romanello V
    J Pathol; 2021 Jul; 254(3):213-215. PubMed ID: 33630303
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cardiac Fgf21 synthesis and release: an autocrine loop for boosting up antioxidant defenses in failing hearts.
    Di Lisa F; Itoh N
    Cardiovasc Res; 2015 Apr; 106(1):1-3. PubMed ID: 25712960
    [No Abstract]   [Full Text] [Related]  

  • 48. Fibroblast growth factor 9 subfamily and the heart.
    Wang S; Li Y; Jiang C; Tian H
    Appl Microbiol Biotechnol; 2018 Jan; 102(2):605-613. PubMed ID: 29198068
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Fibroblast growth factor 21 in heart failure.
    Tucker W; Tucker B; Rye KA; Ong KL
    Heart Fail Rev; 2023 Jan; 28(1):261-272. PubMed ID: 36028609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardioprotective effects of insulin: how intensive insulin therapy may benefit cardiac surgery patients.
    Ng KW; Allen ML; Desai A; Macrae D; Pathan N
    Circulation; 2012 Feb; 125(5):721-8. PubMed ID: 22311884
    [No Abstract]   [Full Text] [Related]  

  • 51. Exercise promotes cardiac-specific fibroblast growth factor 21 expression.
    Guo Y; Liu Q; Gui Y; Liao C; Xu D
    Int J Cardiol; 2016 Jan; 203():532-3. PubMed ID: 26569358
    [No Abstract]   [Full Text] [Related]  

  • 52. Stress and Inflammation in Coronary Artery Disease: A Review Psychoneuroendocrineimmunology-Based.
    Fioranelli M; Bottaccioli AG; Bottaccioli F; Bianchi M; Rovesti M; Roccia MG
    Front Immunol; 2018; 9():2031. PubMed ID: 30237802
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic potential of FGF21 in cardiorenal syndrome.
    Li F; Tang C; Dong Z
    Int J Cardiol; 2016 Jul; 214():70-1. PubMed ID: 27057978
    [No Abstract]   [Full Text] [Related]  

  • 54. Fibroblastic growth factor and infarct size.
    Franco WP; Bracey AW; Franco KL; Hufnagel CA; Glogar DH; Kloner RA
    Ann Intern Med; 1980 Oct; 93(4):637-8. PubMed ID: 6449169
    [No Abstract]   [Full Text] [Related]  

  • 55. FGF21 and Cardiac Physiopathology.
    Planavila A; Redondo-Angulo I; Villarroya F
    Front Endocrinol (Lausanne); 2015; 6():133. PubMed ID: 26379627
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Fibroblast growth factor-21, energy balance and obesity.
    Giralt M; Gavaldà-Navarro A; Villarroya F
    Mol Cell Endocrinol; 2015 Dec; 418 Pt 1():66-73. PubMed ID: 26415590
    [TBL] [Abstract][Full Text] [Related]  

  • 57. FGF21, energy expenditure and weight loss - How much brown fat do you need?
    Straub L; Wolfrum C
    Mol Metab; 2015 Sep; 4(9):605-9. PubMed ID: 26413466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Understanding the Physiology of FGF21.
    Fisher FM; Maratos-Flier E
    Annu Rev Physiol; 2016; 78():223-41. PubMed ID: 26654352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Physiological and Pharmacological Roles of FGF21 in Cardiovascular Diseases.
    Cheng P; Zhang F; Yu L; Lin X; He L; Li X; Lu X; Yan X; Tan Y; Zhang C
    J Diabetes Res; 2016; 2016():1540267. PubMed ID: 27247947
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.